Cargando…
HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor
Human Immunodeficiency Virus (HIV-1) poses a serious threat to the developing world and sexual transmission continues to be the major source of new infections. Therefore, the development of molecules, which prevent new HIV-1 infections, is highly warranted. In the present study, a panel of human hem...
Autores principales: | Bashir, Tahir, Patgaonkar, Mandar, Kumar C, Selvaa, Pasi, Achhelal, Reddy, Kudumula Venkata Rami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411102/ https://www.ncbi.nlm.nih.gov/pubmed/25915507 http://dx.doi.org/10.1371/journal.pone.0124839 |
Ejemplares similares
-
HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro
por: Bashir, Tahir, et al.
Publicado: (2014) -
Expression of hemoglobin-α and β subunits in human vaginal epithelial cells and their functional significance
por: Saha, Debarchana, et al.
Publicado: (2017) -
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019) -
TLR9 and RIG-I Signaling in Human Endocervical Epithelial Cells Modulates Inflammatory Responses of Macrophages and Dendritic Cells In Vitro
por: Sathe, Ameya, et al.
Publicado: (2014) -
Hemoglobin Expression in Nonerythroid Cells: Novel or Ubiquitous?
por: Saha, Debarchana, et al.
Publicado: (2014)